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ABSTRACT
Background    The purpose of this study was to exam-
ine the stigma and coping strategies of patients with type 
1 diabetes.
Methods    Data were collected from 24 adult patients 
with type 1 diabetes via in-depth semi-structured inter-
views that took place in clinic waiting rooms. Qualita-
tive and descriptive data analysis was conducted to iden-
tify stigma and coping strategies of patients with type 1 
diabetes.
Results    Stigma of patients with type 1 diabetes con-
sisted of four categories: (i) “hatred of insulin” due to a 
treatment-oriented lifestyle after the onset of the disease, 
(ii) “imperfect body” due to systemic changes caused 
by the disease, (iii) “social outcast” as a diabetes patient 
who used to be healthy, and (iv) “poor me,” a negative 
self-image due to the responses and attitudes of others. 
Regarding the coping strategies for reducing stigma, the 
following four categories were derived from the anal-
ysis: (i) In a stable disease stage, patients coped with 
stigma by “hiding their disease” or (ii) “pretending to be 
healthy” by avoiding self-care behaviors in public. When 
they told others about their disease, they (iii) “gradually 
spoke out to those around them about their illnesses.” (iv) 
When they could not do either (i) or (ii), they resorted to 
“limiting their social life” or limiting interactions with 
others. 
Conclusion    Patients with type 1 diabetes changed 
their coping strategies for reducing stigma as the disease 
progressed because stigma was tied to their disease. 
Physical, psychological, social, and spiritual coping 
strategies are required to reduce stigma, and the strate-
gies are interrelated. It is important for nurses to assess 
patients from various viewpoints, including the view-
point of stigma.
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Type 1 diabetes is a disease in which pancreatic β cells 
are destroyed and insulin therapy is essential for life sup-
port due to the absolute insulin deficiency. The number 
of patients with type 1 diabetes in Japan is small. They 
account for five percent or less of the total population of 
patients with diabetes.1 The current treatment for type 1 
diabetes is life-sustaining insulin supplementation with 
several daily insulin injections or continuous subcuta-
neous insulin infusion (CSII). Recently, a diet therapy 
called Carb-count has also been introduced.2
 Thus, patients with type 1 diabetes are required to 
incorporate knowledge and activities for controlling 
blood glucose levels with recommended insulin dose 
into their daily lives. This is not easy for the patients. 
Patients with type 1 diabetes have been found to feel 
powerless due to unavoidable life changes, the difficulty 
of appropriate self-management, and misunderstanding 
and prejudice in society.3 If the patients try to have a life 
that is ideal for controlling their blood glucose levels, 
they feel isolated from the community. In addition, it is 
very difficult for them to maintain blood glucose control 
if they want to fulfill their lives, maintaining their roles 
and responsibilities in their families and society. Such 
situations in patients with chronic diseases, including 
diabetes, have been linked to stigma.4 Stigma is defined 
as attributes that add value-deprived identity, which is 
undesirable, contemptible, and distrustful to others, and 
involves “the situation of the individual who is disqual-
ified from full social acceptance” (Goffman, 1963).5 
However, in society, social stigma varies by time and 
region.
 There are many studies of stigma in patients with 
mental diseases or HIV infection. That is because they 
have an inferiority complex about their disease and feel 
inferior in the community. Patients with stigma have 
been reported to have poor social skills and a tendency 
to be tense and anxious, and avoid medical care and 
continuation of treatment (Earnshaw et al., 2015).6
 Although there are fields in which many studies of 
stigma have been conducted, there are very few studies 
(i.e., 13 cases) of stigma in patients with type 1 diabetes. 
Because patients with type 1 diabetes cannot face the 
“stigma” of diabetes, they tend to refuse to use insulin. 
In addition, the younger the patients are at the onset of 
type 1 diabetes, the more susceptible they are to stigma 
because the disease forces them to have a different life-
style (Commissariat et al., 2016).7
 The characteristics of patients with type 1 diabetes 
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in Japan are (i) relatively low age of onset, (ii) small dis-
ease population, and (iii) required insulin supplementa-
tion for the rest of their lives. No study of the stigma has 
been based on these characteristics. Because there have 
been few opportunities to discuss such negative psycho-
logical characteristics of the patients in actual clinical 
settings, their reality has not been fully understood.
 Thus, stigma is a challenge for patients with type 1 
diabetes. The purpose of this study was to examine the 
stigma and coping strategies of patients with type 1 dia-
betes. In this study, by identifying the stigma of patients 
with type 1 diabetes, we expect to get suggestions for 
nursing intervention from the viewpoint of the patients 
so that the patients accept their disease, receive treat-
ment, seek help, and live in the community.
MATERIALS AND METHODS
Definition of terms
Stigma: Negative impression and sense of shame for be-
ing a diabetes patient due to negative responses of others 
and their own sense of values
Coping strategies: Patient behaviors to cope with prob-
lems caused by stigma
Study design
This study used a qualitative exploratory study design 
to examine the stigma and coping strategies of patients 
with type 1 diabetes via semi-structured interviews.
Participants
Patients with type 1 diabetes aged 20 years or older, who 
visited one of the four outpatient departments of internal 
medicine in general hospitals, made negative comments 
about their disease, and hid their disease from others, 
were included in this study.
Data collection
Data were collected between January and March 2013. 
Directors of outpatient departments selected participants 
who were diagnosed with type 1 diabetes and met the 
study requirements. Afterwards, investigators in charge 
confirmed the eligibility of candidates who met the study 
requirements. After eligibility confirmation, the subjects 
were provided with a sufficient explanation of the study 
and written informed consent was obtained prior to 
performing the study procedures. Then, semi-structured 
interviews were conducted with the participants of this 
study. The interview consisted of questions on (i) their 
thoughts at the time of diagnosis with type 1 diabetes, (ii) 
images of type 1 diabetes, (iii) whether they disclosed 
their disease, (iv) responses of others at the time of dis-
closure, and (v) social distress. 
 Basic information, such as age, disease duration, 
treatment approach, HbA1c levels, complications, and 
occupation, was collected from the participants.
Analysis methods
The analysis was conducted using qualitative and de-
scriptive data analysis methods.8 The interviews were 
audio-recorded, transcribed verbatim, and stored for 
analysis. The interview and analysis continued until data 
saturation. Next, the parts in which the participants spe-
cifically talked about their stigma and coping strategies 
were extracted from the verbatim transcriptions. The ex-
tracted parts were classified as data. Next, we performed 
line-by-line coding. While coding, the participants’ own 
words were used as much as possible. The codes were 
then compared to identify differences and similarities, 
and then grouped into categories and subcategories. 
During the entire analysis process, we ensured consis-
tency by consulting with researchers familiar with qual-
itative research. In order to enhance the credibility and 
clarity of our results, we systematically presented the 
verbatim records of the interviews to supervisors famil-
iar with the qualitative study of diabetes nursing.
Ethical considerations
This study was approved by the ethics committee of 
Tottori University. Informed consent was obtained from 
all patients using the procedure approved by the ethics 
committee, and the confidentiality of the participants’ 
information was protected (authorization number 2010). 
Furthermore, participants could stop the interview at 
any point and refuse to answer any questions.
 Parficipants were given pseudonyms to ensure their 
confidentiality and all data were stored securely during 
the analysis process.
RESULTS
Participants
The participants’ basic attributes are shown in Table 1. 
The participants consisted of 5 males and 19 females. 
The age range was 29 to 66 years, and the disease dura-
tion was 3 to 28 years.
 Three categories and 13 subcategories were derived 
from the analysis of the stigma of patients with type 1 
diabetes. Four categories and 11 subcategories were de-
rived from the analysis of coping strategies for reducing 
stigma. For each category, we have provided a storyline 
along with a description.
 Stigma of patients with type 1 diabetes consisted 
of four categories: (i) hatred of insulin due to a treat-
ment-oriented lifestyle after the onset of the disease, (ii) 
“imperfect body” due to systemic changes caused by 
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Table 1. Demographic characteristic of the 24 study 
participant’s with type 1 diabetes
Participant characteristics n
Gender
Male 5
Female 19
Age (years old) 29–66 (39.1 ± 10.5)
Time living with type 1 
diabetes (years) 3–28 (9.8 ± 6.4)
Insulin therapy MDI 20, CSII 4
HbA1c† (NGSP) (%) 6.0–8.5% (7.5 ± 1.1%)
Employment
Full time or part time 16
Unemployed 8
†Glycated hemoglobin.
CSII, continuous subcutaneous insulin infusion; MDI, multiple 
daily injection; NGSP, National Glycohemoglob in Standardiza-
tion Program.
the disease, (iii) “social outcast” as a  socially vulnerable 
diabetes patient who used to be  healthy, and (iv) negative 
self-image due to responses and attitudes of others. Re-
garding the coping strategies for the stigma, the follow-
ing four categories were derived from the analysis: (i)  In 
a stable disease stage, they coped with stigma by “hid-
ing their disease” or (ii) “pretending to be healthy” by 
avoiding self-care behaviors in public. When they told 
others about their disease, they (iii) “gradually spoke out 
to those around them about their illnesses.” (iv) When 
they could do neither (i) nor (ii) anymore, they resorted 
to “limiting their social life” or “limiting interactions 
with others.” The Patients with type 1 diabetes showed a 
tendency to change their coping strategies as the disease 
progressed, going back and forth among the four strate-
gies that are closely interrelated (Table 2, Fig. 1). 
Table 2. Stigma of Patients with Type 1 Diabetes and Their Coping Strategies
Stigma of patients with type 1 diabetes Coping strategies
Category Subcategory Category Subcategory
Hatred of insulin
Insulin makes me aware of the disease
Hiding their disease
I don’t tell others about my disease
Insulin is controlling my life I try to hide my disease from my friends
I do not like injection I tell my kids not to tell others about my disease
I cannot get used to injection
Imperfect body
Body dependent on injections Gradually speaking out 
to those around them 
about their illnesses
I minimized the disclosure of disease
Body that is no longer healthy I underestimate my disease
Body with reduced physical strength
Social outcast
People think I am incompetent
Pretending to be 
healthy
I don’t take insulin in public
People treat me like a sick person I eat and drink whatever they put in front of me
People look down on me I voluntarily quit a job
Poor me
I feel insulted to realize that people mix it 
up with type 2 diabetes
Limiting their social 
life
I reduce the number of people I socialize 
with
I regret having the disease I rarely eat out or go out
I look for a job that doesn’t require me to 
disclose my disease
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Fig. 1. Stigma of patients with type 1 diabetes and their coping strategies. 
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Fig. 1. Stigma of patients with type 1 diabetes and their coping 
strategies.
Stigma of patients with type 1 diabetes
Hatred of insulin
The patients started to receive daily insulin therapy as 
soon as they were diagnosed with type 1 diabetes. In 
order to administer insulin, they became conscious of 
their disease, and sometimes missed the chance to inject 
insulin while at work or when they could not fi nd a place 
to do so. It was found that the patients had a negative 
image of insulin administration and thus hated insulin. 
This category consisted of four subcategories: (i) “ I hate 
injections,” (ii) “I nsulin is controlling my life,” (iii) “I 
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cannot get used to injections,” and (iv) “Insulin makes 
me aware of the disease.” 
At first, I could not accept injections because I hated 
them. But I have no choice. (Case L)
Injections are cumbersome. The most troublesome sit-
uation is where I always have to excuse myself to go to 
the washroom when eating out. (Case I)
I hated to go to the washroom to have injections in the 
middle of work. I could not work when I had hypoglyce-
mia. Because I couldn’t get used to injections, I switched 
to insulin pump therapy. (Case S)
When I am out, I have to take injections in the wash-
room or somewhere else. I hate the disease in such a 
situation. (Case D)
Imperfect body
The patients thought that they would need insulin sup-
plementation for the rest of their lives and that the dis-
ease is not curable. They regarded the systemic changes 
caused by the disease as physical defects.
 This category consisted of three subcategories: (i) 
“Body dependent on injections,” (ii) “Body that is no 
longer healthy,” and (iii) “Body with reduced physical 
strength.” 
It is like I cannot live without (insulin) injections. (Case T)
Whenever I eat too much, I feel heavy and realize that I 
cannot eat anymore. (Case N)
I feel cumbersome because I cannot do anymore what 
I used to do all day without any problems since I devel-
oped hypoglycemia. (Case W)
Social outcast
The patients felt that they have moved from the healthy 
group to the type 1 diabetes group. The patients regard-
ed themselves as socially vulnerable and inferior diabe-
tes patients who used to be healthy.
This category consisted of three subcategories: (i) “Peo-
ple think I am incompetent,” (ii) “People treat me like a 
sick person,” and (iii) “People look down on me.”
When I was looking for a job, I failed employment tests 
because of my disease. (Case J)
My colleagues are concerned about my health. People 
around me are really concerned about me. And I don’t 
like that. (Case U)
People probably look down on me because type 2 dia-
betes is more common than type 1 diabetes. (Case X)
Poor me
When the patient suddenly developed type 1 diabetes, 
not because of lifestyle mismanagement, he felt miser-
able because people misunderstood and thought that he 
had type 2 diabetes. That made his self-image worse, 
and he started to interpret things negatively. This catego-
ry consisted of two subcategories: (i) “I feel insulted to 
realize that people mix it up with type 2 diabetes;” and (ii) 
“I regret having the disease.” 
I felt hurt when people around me told me that I was 
lazy or when people said that you got what you de-
served. (Case E)
I cried from shock when I got type 1 diabetes at a young 
age. (Case F)
I wish I got this disease ten years later. Really. (Case K)
Coping strategies of patients with type 1 diabetes
Hiding the disease
As a coping strategy for the stigma, patients with type 
1 diabetes hide their disease from others. This category 
consisted of three subcategories: (i) “I don’t tell others 
about my disease,” (ii) “I try to hide my disease from 
my friends,” and (iii) “I taught my kids not to tell others 
about my disease.” 
I never tell others that I have type 1 diabetes. I always 
carry insulin, but I never tell others about it. (Case C)
My friends don’t know about it. Well, I never tell them 
about my type 1 diabetes, and just tell them that I have 
to go to washroom. (Case G)
I always tell my kids not to tell them that I take insulin 
injections. Because I heard that the children of diabetic 
mothers can get bullied at school. Because most people 
would misunderstand if my kid tells them that I take in-
jections. (Case P)
Pretending to be healthy
Although patients recognized that they must take nec-
essary medications, regardless of whether they have al-
ready told others about their disease, they usually avoid-
ed taking necessary medications in public. This category 
consisted of three subcategories: (i) “I don’t take insulin 
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in public,” (ii) “I eat and drink whatever they put in front 
of me,” and (iii) “I voluntarily quit a job.” 
When I need an injection, I go to the washroom or do it 
in my car without telling anyone about it. (Case R)
I simply eat sweets when my colleagues offer them to 
me. I can’t say no. (Case O)
Because of my personality, I knew that I would quit the 
job someday, regardless of whether I got sick or not. 
(Case B)
I had to quit my job. (Case G)
Gradually speaking out to those around them about their 
illnesses
Patients did not make any attempt to hide they had dia-
betes and disclosed their illness in steps and watched the 
reaction. The patients joked about their disease so that 
people don’t take it as a serious disease. This category 
consisted of two subcategories: (i) “I minimized the 
disclosure of disease” and (ii) “I underestimate my dis-
ease.” 
I tell my friends that I have an “incurable disease.” I 
joke about my disease so that people don’t take it as a 
serious one. (Case N)
I try not to think about my disease because it makes me 
sad. (Case V)
Limit social life
In order to manage the disease, the patients reduced 
their relationships with those who did not understand 
their disease or those to whom they had to disclose their 
disease. In addition, they chose a job that did not require 
them to disclose their disease. This category consisted of 
three subcategories: (i) “I reduce the number of people I 
socialize with,” (ii) “I rarely eat out or go out,” and (iii) 
“I look for a job that doesn’t require me to disclose my 
disease.” 
I can’t go out unless I have something to do. I am afraid 
to meet people. I have stopped seeing friends who used 
to be close to me. (Case H)
I try to avoid a drinking party. Even if someone asks me 
to go, I decline the invitation. (Case M)
I would like to work when my kid starts grade 1. The 
work can be anything, but hopefully one that does not 
require me to disclose my disease. (Case Q)
DISCUSSION
Characteristics of stigma of patients with type 1 
diabetes
It has been shown that patients with type 1 diabetes face 
physical (i.e., “imperfect body”), psychological (i.e., “ha-
tred of insulin”), social (i.e., “social outcast”), and spir-
itual (i.e., “poor me”) stigmas. These four stigmas (i.e., 
physical, psychological, social, and spiritual) were found 
to be inseparable and interrelated. The results showed 
total pain, as in cancer patients.9 Thus, patients with type 
1 diabetes face stigma consisting of four aspects. It was 
found that psychological stigma leads to physical, social, 
and then spiritual stigma. This is the structure of stigma 
found in this study. We believe that the negative spiral 
of these stigmas reduces self-care behaviors and exacer-
bates blood glucose and HbA1c levels, leading to devas-
tating health consequences. In addition, the development 
and progression of type 1 diabetes has a great impact on 
patients’ relationships and social roles, causing work and 
family problems. Because social stigma shows social 
rejection, social stigma is an important indicator that is 
related to physical, psychological, and spiritual stigmas. 
The negative spiral of these stigmas shares common 
causes with the one described by Goffman (1968)5 and 
Robert (1984).10 Stigma of patients with chronic depres-
sion has been reported to be due to a sense of shame, 
fear, lack of trust, lack of close relationships, and lack of 
communication.11 In patients with type 2 diabetes, the 
disease creates negative images and internalizes itself 
as stigma.12 The current study also found similar results, 
showing that the stigma of patients with type 1 diabetes 
was due to a sense of shame, fear, lack of trust, and lack 
of relationship. Type 1 diabetes seems to create negative 
images, leading to stigma.
 Unlike patients with type 2 diabetes, patients with 
type 1 diabetes require insulin supplementation for the 
rest of their lives, experiencing a stigma of “hatred of 
insulin.” Jaacks (2015)13 stated that patients with type 
1 diabetes can reduce stigma of insulin by switching to 
insulin pump therapy. However, the current study could 
not replicate their findings.
 Type 1 diabetes develops suddenly. As soon as 
patients are diagnosed with type 1 diabetes, they are re-
quired to learn proper insulin injection techniques. Hy-
poglycemia or hyperglycemia appears in patients with 
type 1 diabetes when their blood glucose levels remain 
unstable due to improper blood glucose control (HbA1c). 
Thus, they are very aware of their disease. This makes 
them feel bad and discourages self-care behaviors.3 This 
in turn leads to the stigma of an “imperfect body” such 
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as (i) “Body dependent on injections,” (ii) “Body that is 
no longer healthy,” and (iii) “Body with reduced phys-
ical strength.” Because some of the participants in this 
study were employed, work-related stigma (i.e., “social 
outcast”) was also derived. They face social stigma 
because people think they are incompetent because of 
type 1 diabetes. In particular, insulin injections give an 
impression that the patients have severe diabetes, lead-
ing to discrimination and unfounded judgment that they 
cannot even handle typical tasks.14 This in turn leads to 
the spiritual stigma of “social outcast” such as (i) “People 
think I am incompetent,” (ii) “People treat me like a sick 
person,” (iii)  “People look down on me,” and (iv) “poor 
me,” a negative self-image due to the responses and atti-
tudes of others. 
 Type 2 diabetes is more common than type 1 dia-
betes. People blamed me for developing type 1 diabetes, 
which they thought was basically the same disease as 
type 2 diabetes despite the different onset mechanisms. 
Thus, the patients feel discriminated against and have a 
tendency to think that type 1 diabetes ruined their lives. 
This leads to the stigma of “poor me.” Once patients 
with type 1 diabetes’ relationships with others get worse, 
that affects their identity and self-esteem, leading to 
excessive self-denial.7 The current study found the same 
results, showing that it leads to the stigma of “poor me.”
 
Coping strategies of patients with type 1 diabetes
Patients with type 1 diabetes were found to cope with 
stigma by “hiding their disease.” Most patients with 
type 1 diabetes look totally normal and healthy. Thus, 
patients with type 1 diabetes who look totally healthy 
resort to coping strategies such as (i) “I don’t tell my 
colleagues about my disease,” (ii)  “I don’t take insulin 
in public,” and (iii) “I voluntarily quit a job,” in order to 
secure their job and income. 
 In patients with type 1 diabetes, symptoms of hy-
poglycemia and hyperglycemia appear if they cannot 
adjust food and insulin intake, and if the symptoms get 
worse, they will be hospitalized. Even if their disease 
worsens, when no symptoms are present, they hide their 
disease by gradually speaking out to those around them 
about their illnesses or by pretending to be healthy, de-
pending on the conditions. According to Holm (2014),15 
people with chronic diseases do not want to let others 
know about their disease and are hesitant to perform 
self-care behaviors in public. There are similar findings 
in patients with type 1 diabetes.16 Because insulin injec-
tions make patients with type 1 diabetes aware of the 
disease, they resort to coping strategies as they gradually 
speak out to those around them about their illnesses or 
by pretending to be healthy in order to avoid self-care 
behaviors.
 However, the results of this study show that the cop-
ing strategy of “pretending to be healthy” was developed 
through patients’ efforts to cope with the disease rather 
than behaviors resulting from lack of knowledge of the 
disease.
 As the disease progresses, the patients became 
more aware of their disease, started to avoid self-care 
behaviors, and could not resort to coping strategies such 
as “hiding their disease” or “pretending to be healthy.” 
Then, as the last resort, they “limited their interactions 
with others.” Patients can create a comfortable envi-
ronment by intentionally underestimating the severity 
of their disease, reducing social stigma.17 In this way, 
the patients coped with stigma by “limiting their social 
life.” Two coping strategies, i.e., “I reduce the number 
of people I socialize with” and “I rarely eat out or go 
out,” seem to be the results of their efforts not only to 
hide their disease, but also to  facilitate their social life. 
However, when patients could not hide their disease 
anymore, they minimized the disclosure of the disease 
or pretended that their disease was not so serious, de-
pending on the situation. Patients with type 1 diabetes 
seem to be manipulating information about their disease 
in order to avoid discrimination and bitter experiences 
and to maintain their quality of life. Those two strategies 
of “hiding their disease” and “limiting their social life” 
sound negative. However, nurses need to understand the 
meaning of such patient behaviors because these are sig-
nificantly painful experiences for the patients.
Suggestions for nursing from the viewpoint of 
stigma
Patients with type 1 diabetes face stigma as do other 
patients with chronic diseases. Their tendency to asso-
ciate the disease with stigma was found to affect their 
self-care behaviors. We believe that nurses should make 
assessments from the viewpoint of stigma when the 
patients are in situations where they reject disclosure of 
their disease and avoid taking insulin injections or per-
forming self-care behaviors in public. In this study, both 
the viewpoints of the patient (the change of the patient/
oneself) and the surrounding people (including support 
from those people) are important. 
 To whom, when, and how to disclose their disease 
should also be considered. It might be possible for them 
to disclose their disease by gradually speaking out to 
those around them about their illnesses at the right time 
with confidence.
 What is noteworthy in this study is that the view-
points of the patient (change of one’s self) and surround-
ing people (including support from people around the 
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patient) are mutually helpful, that is, helpful to both the 
patient and the people around them. It is necessary to 
provide a space to inform people about type 1 diabetes 
through public awareness campaigns and ensure that 
type 1 diabetes patients interact with each other so that 
we can better support them. However, this coping strat-
egy might be effective in balancing their social life and 
self-care behaviors if the patients know blood glucose 
control methods that fit their lifestyle. Although they hid 
their disease by gradually speaking out to those around 
them about their illnesses in the early stages, most pa-
tients became more dependent on the strategy of “limiting 
their social life” as the disease progressed. If the patients 
cannot do self-management due to stigma, it is important 
for us to show them an example of the coping strategy of 
gradually speaking out to those around them about their 
illnesses, discuss with them how to control blood glu-
cose levels without being noticed, and help them change 
their self-care behaviors in the early stages before the 
disease gets worse. For that purpose, it is also desirable 
to discuss with patients their living conditions, social 
life, and relationships in order to assess their stigma.
 As described above, assessment of patients from 
the viewpoint of stigma can provide nurses with a new 
viewpoint of intervention to support patients with type 1 
diabetes’ lives.
Limitations of this study
In this study, stigma and the coping strategies for it were 
derived from 24 participants. The analysis was conduct-
ed using a qualitative data analysis method. Although it 
was difficult to generalize the results, we were able to re-
duce sampling bias. However, we did not have an oppor-
tunity to observe the nursing support for patients with 
stigma. Therefore, there may be other stigma coping 
strategies that are not covered in this study. Further, to 
ensure that the study is reliable, I used the triangulation 
method to reduce sampling bias. Future studies should 
focus on a more refined approach including the analysis 
of observational studies.
The authors declare no conflict of interest.
REFERENCES
  1 The Japan Diabetes Society. Treatment Guide for Diabetes. 
Tokyo: Bunkodo; 2016-2017. p. 92-3.
  2 American Diabetes Association. Standard of medical care in 
diabetes 2015. Diabetes Care. 2015;38:S5-S76.
  3 Nishio I, Chujo M, Kataoka H. A Qualitative Study of Con-
fusing Experiences among Japanese Adult Patients with 
Type 1 Diabetes. Yonago Acta Med. 2016;59:81-8. PMID: 
27046954.
  4 McGonagle AK, Barnes-Farrell JL. Chronic illness in the 
workplace: stigma, identity threat and strain. Stress Health. 
2014;30:310-21. PMID: 23955842.
  5 Goffman. Stigma: Notes on the Management of Spoiled Iden-
tity. New York: Simon & Schuster; 1968. p. 12-5.
  6 Earnshaw VA, Smith LR, Cunningham CO, Copenhaver MM. 
Intersectionality of internalized HIV stigma and internalized 
substance use stigma: Implications for depressive symptoms. J 
Health Psychol. 2015;20:1083-9. PMID: 24170015.
  7 Commissariat PV, Kenowitz JR, Trast J, Heptulla RA, 
Gonzalez JS. Developing a Personal and Social Identity 
With Type 1 Diabetes During Adolescence: A Hypothesis 
Generative Study. Qual Health Res. 2016 ;26:672-84. PMID: 
26893304.
  8 Patrick W. Corrigan. The stigma of mental illness: Explana-
tory models and methods for change. 2005;11:179-90. DOI: 
10.1016/j.appsy.2005.07.001.
  9 Chou FY, Lee-Lin F, Kuang LY. The Effectiveness of Sup-
port Groups in Asian Breast Cancer Patients: An Integrative 
Review. Asia Pac J Oncol Nurs. 2016;3:157-169. PMID: 
27981154.
10 Robert. Stigma. London: Routledge & Kegan Paul; 1984. p. 
1-24.
11 Liu NF, Brown AS, Younge MF, Guzman SJ, Close KL, 
Wood R. Stigma in People with Type 1 or Type 2 Diabetes. 
Clin Diabetes. 2017;35:27-34. PMID: 28144043; DOI: 10.2337/
cd16-0020.
12 Kato A, Fujimaki Y, Fujimori S, Izumida Y, Suzuki R, Ueki 
K, et al. A qualitative study on the impact of internalized stig-
ma on type 2 diabetes self-management. Patient Educ Couns. 
2016;99:1233-9. PMID: 27873575.
13 Jaacks LM, Liu W, Ji L, Mayer-Davis EJ. Type 1 diabetes stig-
ma in China: a call to end the devaluation of individuals living 
with a manageable chronic disease. Diabetes Res Clin Pract. 
2015;107:306-7. PMID: 25547225.
14 Shiu AT, Wong RY, Thompson DR. Development of a reliable 
and valid Chinese version of the diabetes empowerment scale. 
Diabetes Care. 2003;26:2817-21. PMID:14514585.
15 Holm AL, Severinsson E. Perceptions of the need for im-
provements in healthcare after implementation of the Chron-
ic Care Model. Nurs Health Sci. 2014;16:442-8. PMID: 
24785824.
16 Watts S, O’Hara L, Trigg R. Living with type 1 diabetes: a 
by-person qualitative exploration. Psychol Health. 2010;25:491-
506. PMID: 20204938. 
17 Brown RL. Perceived Stigma Among People With Chronic 
Health Conditions: The Influence of Age, Stressor Exposure, 
and Psychosocial Resources. Research on Aging. 2015;37:335-
60. DOI: 10.1177/0164027514533133. 
